ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:49 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual Feature analysis: loss_cnaPANCAN359_(CUL3)
Feature details and cell panel numbers
Binary feature equal to 1 for samples having the genomic region(s) cnaPANCAN359_(CUL3) deleted (see genomic region decoding file for further infos on this region)
Number of cell lines positive for this feature: 22
Statistically significant associations identified = 5
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a146 |
loss_cnaPANCAN359_(CUL3) |
290 |
1 |
1 |
KIN001-260 |
IKK |
18 |
900 |
3 |
4.58 |
5.51 |
0.935 |
0.78 . |
0.77 . |
1.8 * |
3.61e-05 |
2.04e-85 |
8.01e-01 |
4.1 |
a220 |
loss_cnaPANCAN359_(CUL3) |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
19 |
894 |
3.47 |
3.53 |
5.1 |
1.57 |
0.89 . |
0.88 . |
1.4 * |
1.06e-04 |
1.73e-45 |
2.31e-01 |
7.9 |
a419 |
loss_cnaPANCAN359_(CUL3) |
1149 |
1 |
1 |
TW 37 |
BCL2, BCL2L1 |
19 |
898 |
1.61 |
-0.552 |
0.25 |
0.803 |
0.68 . |
0.68 . |
0.63 . |
5.14e-04 |
7.93e-16 |
5.87e-05 |
20 |
a509 |
loss_cnaPANCAN359_(CUL3) |
287 |
1 |
1 |
KIN001-244 |
PDPK1 (PDK1) |
18 |
900 |
3 |
3.26 |
4.2 |
0.942 |
0.75 . |
0.75 . |
0.94 . |
7.52e-04 |
3.66e-42 |
6.14e-01 |
24 |
a524 |
loss_cnaPANCAN359_(CUL3) |
309 |
1 |
1 |
Y-39983 |
ROCK |
18 |
901 |
3 |
4.29 |
5.17 |
0.884 |
0.64 . |
0.64 . |
0.94 . |
7.86e-04 |
2.62e-53 |
4.15e-02 |
25 |
All-tests volcano plot